The France Bariatric Surgery Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 13.2% during the forecast period, 2023 – 2031. The growth of market is attributed to increasing number of stout patients in the population and ubiquitous rate of Type-2 heart and diabetic diseases.
The major cause of obesity is metabolic dysfunction and a wide range of chronic illness associated with it that becomes the significant cause of increase in mortality rates. The factors such as misbalance of quality of life, considerable amount of healthcare, and premature mortality are found majorly in the patients suffering from obesity.
The diseases associated with obesity includes stroke, sleep apnea, osteoarthritis, hypertension, and Type-2 diabetes, thus obesity is undoubtedly considered as one of the primary cause of diabetes and by far bariatric surgery is been one of the most efficient method to control both.
According to 2019 report of organization of economic co-operation and development (OECD), every 1 out of 10th person in France, and approximately 40% of the Frances’ population is overweight or suffering from obesity, furthermore it is clear indication that in the coming years the overweight rates will escalate by 10% or even more.
Moreover with the sudden appearance of new and advance technologies in bariatric surgery segment and increasing demand for minimally invasive surgical process is anticipated to augment the market growth in the coming years. Bariatric procedure is witnessing a drastic demand increase in France which is expected to double the growth in the European market.
Market Trends, Drivers, Restraints, and Opportunities
-
Increasing obese population and rising prevalence of heart and diabetes diseases is expected to propel the market during the forecast period.
-
Wide range of chronic diseases associated with obesity and growing mortality rate is estimated to fuel the market during projected period.
-
Growing demand for surgeries which involves minimal invasive techniques is anticipated to boost the market in coming years.
-
Increasing dis-balance in work life balance and frequent changes in lifestyle and eating habits is expected to spike the market during the forecast period.
-
High cost associated with surgery act as a factor that can hinder the market growth during the projected period.
-
R&D and technological advancement in bariatric surgery and rapid adoption of these surgeries in developing markets creates a lucrative opportunities for the key player of the market during the projected period.
Scope of the market
The report on the France bariatric surgery market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Bariatric surgery market – France Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Devices (Assisting Devices [Trocars, Stapling Devices, Closure Devices, Suturing Devices, Clip Appliers, and Others], Implantable Devices [Electrical Stimulations Devices, Gastric Bands, Gastric Balloons, and Others], and Other Devices)
|
|
Country
|
France
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
B.Braun Melsungen AG; Conmed Corporation; Apollo Endosurgery Inc.; Medtronic PLC (Covidien PLC); Johnson and Johnson (Ethicon Inc).
|
Market segment insights
The stapling devices segment is expected to constitute major share of the market
Based on devices, the market is segregated into assisting devices, implantable devices, and others. The assisting devices segment is further segregated into trocars, stapling devices, closure devices, suturing devices, clip appliers, and others. The implantable devices segment is sub-segregated into electrical stimulations devices, gastric bands, gastric balloons, and others. The stapling devices segment is expected to constitute major share of the market during the forecast period due to the most commonly used and available device, as it tends to result in greater and more effective fat loss among the sufferers accompanied with reducing the health problem closely linked with obesity.
Segments
France bariatric surgery market has been segmented on the basis of
Devices
- Assisting Devices
- Trocars
- Stapling Devices
- Closure Devices
- Suturing Devices
- Clip Appliers
- Others
- Implantable Devices
- Electrical Stimulations Devices
- Gastric Bands
- Gastric Balloons
- Others
Country
Key Players
- B.Braun Melsungen AG
- Conmed Corporation
- Apollo Endosurgery Inc.
- Medtronic PLC (Covidien PLC)
- Johnson and Johnson (Ethicon Inc).
Competitive Landscape
Key players competing in the France bariatric surgery coffee market include B.Braun Melsungen AG; Conmed Corporation; Apollo Endosurgery Inc.; Medtronic PLC (Covidien PLC); Johnson and Johnson (Ethicon Inc).
Some of these players are targeting on business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Request For Customization
Enquiry Before Buying
Speak With Analyst
